Literature DB >> 10947820

Porcine neural progenitors require commitment to the oligodendrocyte lineage prior to transplantation in order to achieve significant remyelination of demyelinated lesions in the adult CNS.

P M Smith1, W F Blakemore.   

Abstract

Glial cell transplantation is a potential therapy for human demyelinating disease, though obtaining large numbers of oligodendrocyte precursors from nonrodent species is currently problematic. Culturing of multipotent neural progenitors may provide a solution to this problem, because these cells can be expanded in vitro whilst retaining the ability to differentiate into both neurons and glial cells. In order to investigate the myelinating capability of multipotent neural progenitors, we isolated cells from the porcine subventricular zone, a region rich in neural progenitors, and transplanted them into areas of persistent demyelination in the spinal cord of immunosuppressed rats, created by the injection of ethidium bromide and subsequent exposure to 40 Gy X-irradiation. Porcine SVZ cells were transplanted either within 12 h of isolation or after 7 days in B104-conditioned medium. Freshly isolated cells did not mature into myelinating oligodendrocytes following transplantation and instead remained as clusters of undifferentiated progenitors. However, cells exposed to B104-conditioned medium prior to transplantation were able to effect complete remyelination of the demyelinated axons. This suggests that neural progenitors must be manipulated in vitro for commitment to the oligodendrocyte lineage prior to transplantation if significant remyelination is to be achieved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947820     DOI: 10.1046/j.1460-9568.2000.00137.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  9 in total

Review 1.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

Review 2.  Glial grafting for demyelinating disease.

Authors:  V Tepavcević; W F Blakemore
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

3.  Magnetic resonance imaging evaluation of Yukatan minipig brains for neurotherapy applications.

Authors:  Seung Pil Yun; Dong Hyun Kim; Jung Min Ryu; Jae Hong Park; Su Shin Park; Ji Hoon Jeon; Bit Na Seo; Hyun-Jeong Kim; Jun-Gyu Park; Kyoung-Oh Cho; Ho Jae Han
Journal:  Lab Anim Res       Date:  2011-12-19

4.  Spontaneous differentiation of porcine neural progenitors in vitro.

Authors:  Fei Yin; Li Guo; Ri-Feng Lu; Qing-San Zhu
Journal:  Cytotechnology       Date:  2011-04-05       Impact factor: 2.058

5.  Differing in vitro survival dependency of mouse and rat NG2+ oligodendroglial progenitor cells.

Authors:  Makoto Horiuchi; Tullia Lindsten; David Pleasure; Takayuki Itoh
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

6.  Interplay of hormones and p53 in modulating gender dimorphism of subventricular zone cell number.

Authors:  Jin Young Kim; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

Review 7.  Myelin repair: the role of stem and precursor cells in multiple sclerosis.

Authors:  Siddharthan Chandran; David Hunt; Alexis Joannides; Chao Zhao; Alastair Compston; Robin J M Franklin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

8.  Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats.

Authors:  Howard Kim; Tasneem Zahir; Charles H Tator; Molly S Shoichet
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

9.  Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?

Authors:  Sara Xapelli; Fabienne Agasse; Sofia Grade; Liliana Bernardino; Filipa F Ribeiro; Clarissa S Schitine; Andrea S Heimann; Emer S Ferro; Ana M Sebastião; Ricardo A De Melo Reis; João O Malva
Journal:  Front Cell Neurosci       Date:  2014-02-27       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.